Shoichi Takikita
Overview
Explore the profile of Shoichi Takikita including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
683
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Takikita S, Muro R, Takai T, Otsubo T, Kawamura Y, Dohi T, et al.
J Immunol
. 2016 Aug;
197(6):2269-79.
PMID: 27511731
ESET/SETDB1, one of the major histone methyltransferases, catalyzes histone 3 lysine 9 (H3K9) trimethylation. ESET is critical for suppressing expression of retroviral elements in embryonic stem cells; however, its role...
2.
Takikita S, Takano T, Narita T, Maruo Y
Mol Genet Metab Rep
. 2016 Mar;
4:25-9.
PMID: 26937406
Hypomyelination in developing brain is often accompanied by congenital metabolic disorders. Menkes kinky hair disease is an X-linked neurodegenerative disease of impaired copper transport, resulting from a mutation of the...
3.
Hasumi H, Baba M, Hasumi Y, Huang Y, Oh H, Hughes R, et al.
J Natl Cancer Inst
. 2012 Nov;
104(22):1750-64.
PMID: 23150719
Background: Birt-Hogg-Dubé (BHD) syndrome is a hereditary hamartoma syndrome that predisposes patients to develop hair follicle tumors, lung cysts, and kidney cancer. Genetic studies of BHD patients have uncovered the...
4.
Takikita S, Schreiner C, Baum R, Xie T, Ralston E, Plotz P, et al.
PLoS One
. 2010 Dec;
5(12):e15239.
PMID: 21179212
PGC-1α is a transcriptional co-activator that plays a central role in the regulation of energy metabolism. Our interest in this protein was driven by its ability to promote muscle remodeling....
5.
Raben N, Schreiner C, Baum R, Takikita S, Xu S, Xie T, et al.
Autophagy
. 2010 Sep;
6(8):1078-89.
PMID: 20861693
Autophagy, an intracellular system for delivering portions of cytoplasm and damaged organelles to lysosomes for degradation/recycling, plays a role in many physiological processes and is disturbed in many diseases. We...
6.
Douillard-Guilloux G, Raben N, Takikita S, Ferry A, Vignaud A, Guillet-Deniau I, et al.
Hum Mol Genet
. 2009 Dec;
19(4):684-96.
PMID: 19959526
Glycogen storage disease type II (GSDII) or Pompe disease is an autosomal recessive disorder caused by acid alpha-glucosidase (GAA) deficiency, leading to lysosomal glycogen accumulation. Affected individuals store glycogen mainly...
7.
Takikita S, Myerowitz R, Schreiner C, Baum R, Raben N, Plotz P
Autophagy
. 2009 Jul;
5(5):729-31.
PMID: 19571661
In Pompe disease, a lysosomal glycogen storage disorder, cardiac and skeletal muscle abnormalities are responsible for premature death and severe weakness. Swollen glycogen-filled lysosomes, the expected pathology, are accompanied in...
8.
Takikita S, Myerowitz R, Zaal K, Raben N, Plotz P
Mol Genet Metab
. 2009 Jan;
96(4):208-17.
PMID: 19167256
Lysosomes filled with glycogen are a major pathologic feature of Pompe disease, a fatal myopathy and cardiomyopathy caused by a deficiency of the glycogen-degrading lysosomal enzyme, acid alpha-glucosidase (GAA). To...
9.
Raben N, Baum R, Schreiner C, Takikita S, Mizushima N, Ralston E, et al.
Autophagy
. 2008 Nov;
5(1):111-3.
PMID: 19001870
The role of autophagy, a catabolic lysosome-dependent pathway, has recently been recognized in a variety of disorders, including Pompe disease, which results from a deficiency of the glycogen-degrading lysosomal hydrolase...
10.
Douillard-Guilloux G, Raben N, Takikita S, Batista L, Caillaud C, Richard E
Hum Mol Genet
. 2008 Sep;
17(24):3876-86.
PMID: 18782850
Glycogen storage disease type II (GSDII) or Pompe disease is an autosomal recessive disorder caused by defects in the acid alpha-glucosidase gene, which leads to lysosomal glycogen accumulation and enlargement...